OBJECTIVE: The author's goal was to investigate relationships between peripheral thyroid hormone levels and cerebral blood flow (CBF) and cerebral glucose metabolism in affectively ill patients. METHOD: Medication-free inpatients with major depression or bipolar disorder were studied with oxygen-15 water and positron emission tomography (PET) to measure CBF (N = 19) or with [18F] fluorodeoxyglucose and PET to measure cerebral glucose metabolism (N = 29). Linear regression was used to correlate global CBF and cerebral glucose metabolism with serum thyrotropin-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), and free T4 concentrations. Statistical parametric mapping was used to correlate regional CBF and cerebral glucose metabolism with these thyroid indexes. Post hoc t tests were used to further explore the relationships between serum TSH and global CBF and cerebral glucose metabolism. RESULTS: Serum TSH was inversely related to both global and regional CBF and cerebral glucose metabolism. These relationships persisted in the cerebral glucose metabolism analysis and, to a lesser extent, in the CBF analysis after severity of depression had been controlled for. In contrast, no significant relationships were observed between T3, T4, or free T4 and global or regional CBF and cerebral glucose metabolism. CONCLUSIONS: These data suggest that peripheral TSH (putatively the best marker of thyroid status) is inversely related to global and regional CBF and cerebral glucose metabolism. These findings indicate relationships between thyroid and cerebral activity that could provide mechanistic hypotheses for thyroid contributions to primary and secondary mood disorders and the psychotropic effects of thyroid axis manipulations.
OBJECTIVE: The author's goal was to investigate relationships between peripheral thyroid hormone levels and cerebral blood flow (CBF) and cerebral glucose metabolism in affectively ill patients. METHOD: Medication-free inpatients with major depression or bipolar disorder were studied with oxygen-15water and positron emission tomography (PET) to measure CBF (N = 19) or with [18F] fluorodeoxyglucose and PET to measure cerebral glucose metabolism (N = 29). Linear regression was used to correlate global CBF and cerebral glucose metabolism with serum thyrotropin-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), and free T4 concentrations. Statistical parametric mapping was used to correlate regional CBF and cerebral glucose metabolism with these thyroid indexes. Post hoc t tests were used to further explore the relationships between serum TSH and global CBF and cerebral glucose metabolism. RESULTS: Serum TSH was inversely related to both global and regional CBF and cerebral glucose metabolism. These relationships persisted in the cerebral glucose metabolism analysis and, to a lesser extent, in the CBF analysis after severity of depression had been controlled for. In contrast, no significant relationships were observed between T3, T4, or free T4 and global or regional CBF and cerebral glucose metabolism. CONCLUSIONS: These data suggest that peripheral TSH (putatively the best marker of thyroid status) is inversely related to global and regional CBF and cerebral glucose metabolism. These findings indicate relationships between thyroid and cerebral activity that could provide mechanistic hypotheses for thyroid contributions to primary and secondary mood disorders and the psychotropic effects of thyroid axis manipulations.
Authors: Q Miao; S Zhang; Y H Guan; H Y Ye; Z Y Zhang; Q Y Zhang; R D Xue; M F Zeng; C T Zuo; Y M Li Journal: AJNR Am J Neuroradiol Date: 2011-05-19 Impact factor: 3.825
Authors: Yong-Wook Shin; Yun Mi Choi; Ho Sung Kim; Dae-Jin Kim; Hang Joon Jo; Brian F O'Donnell; Eun Kyung Jang; Tae Yong Kim; Young Kee Shong; Jin Pyo Hong; Won Bae Kim Journal: Thyroid Date: 2016-04-11 Impact factor: 6.568
Authors: Carrie E Bearden; Paul M Thompson; Rebecca A Dutton; Benício N Frey; Marco A M Peluso; Mark Nicoletti; Nicole Dierschke; Kiralee M Hayashi; Andrea D Klunder; David C Glahn; Paolo Brambilla; Roberto B Sassi; Alan G Mallinger; Jair C Soares Journal: Neuropsychopharmacology Date: 2007-08-08 Impact factor: 7.853
Authors: Maged M Costantine; Karen Smith; Elizabeth A Thom; Brian M Casey; Alan M Peaceman; Michael W Varner; Yoram Sorokin; Uma M Reddy; Ronald J Wapner; Kim Boggess; Alan T N Tita; Dwight J Rouse; Baha Sibai; Jay D Iams; Brian M Mercer; Jorge E Tolosa; Steve N Caritis; J Peter VanDorsten Journal: Obstet Gynecol Date: 2020-04 Impact factor: 7.623
Authors: Hyo Jung Choi; Min Soo Byun; Dahyun Yi; Bo Kyung Sohn; Jun Ho Lee; Jun-Young Lee; Yu Kyung Kim; Dong Young Lee Journal: Alzheimers Res Ther Date: 2017-08-17 Impact factor: 6.982